Foetal pig neuroblasts are interesting candidates as a cell source for transplantation, but xenotransplantation in the brain requires the development of adapted immunosuppressive treatments. As systemic administration of high doses of cyclosporine A has side effects and does not protect xenotransplants forever, we focused our work on local control of the host immune responses. We studied the advantage of cotransplanting syngenic mesenchymal stem cells (MSC) with porcine neuroblasts (pNb) in immunocompetent rat striata. Two groups of animals were transplanted, either with pNb alone or with both MSC and pNb. At day 63, no porcine neurons were detected in the striata that received only pNb, while four of six rats transplanted with both pNb and MSC exhibited healthy porcine neurons. Interestingly, 50% of the cotransplanted rats displayed healthy grafts with pNF70+ and TH+ neurons at 120 days post-transplantation. qPCR analyses revealed a general dwindling of pro-and anti-inflammatory cytokines in the striata that received the cotransplants. Motor recovery was also observed following the transplantation of pNb and MSC in a rat model of Parkinson's disease. Taken together, the present data indicate that the immunosuppressive properties of MSC are of great interest for the long-term survival of xenogeneic neurons in the brain.
Introduction
Transplantation is a promising approach for nervous system repair in neurodegenerative disorders. Clinical studies have shown beneficial effects following the transplantation of embryonic ventral mesencephalic tissue into the brains of Parkinson's disease patients, but the absence of effects or the apparition of dyskinesia in some patients has underlined the need for technical improvements. These include a better control of the host immune response, as alloimmunization to donor antigens has been observed following the transplantation of foetal neural cells into the brains of patients affected by Huntington's disease [1] . Alternative sources of transplantable cells have also to be found as the use of human foetal tissues raises ethical and logistical problems. In this perspective, we have been studying the possibility of using porcine embryonic ventral mesencephalic tissue [2] [3] [4] . Porcine foetal neurons have been shown to restore behavioural function in animal models of Parkinson's disease [5, 6] and some clinical trials have already been performed [7] [8] [9] . However, despite the particular immunological status of the brain, neuronal xenografts become the target of a host immune response characterized by a massive infiltration of dendritic and T cells with a Th1 profile [3, 4] . Treatment with minocycline [10] or cyclosporine A significantly delays the rejection without inhibiting it. Interestingly, mesenchymal stem cells (MSC) showed spontaneous long-term survival following their transplantation into the brain of a xenogeneic host [11, 12] . This long-term survival is due not only to the low immunogenicity of MSC but also to their active immunosuppressive activity. Indeed, MSC can inhibit the maturation of dendritic cells and proliferation of T-and B cells [13, 14] . Interestingly, transplantation of MSC in animal models of stroke or multiple sclerosis revealed that these cells may have beneficial effects through their immune and trophic properties [15] . Consequently, we decided to take advantage of these properties to develop a local immunosuppressive strategy in the brain. Our results showed that MSC protect xenogeneic neural cells from cell rejection without affecting their functional properties.
Materials and methods

Animals
Porcine embryos were obtained from domestic Large White pigs 28 days after insemination (G28; Institut National de la Recherche Agronomique, INRA, Nouzilly, France). Lewis 1A and Sprague-Dawley wild-type rats were purchased from Janvier CERJ (Le Genest saint Isle, France) and Charles River (L'Arbresle, France). The experiments were performed according to the French guidelines for the care and use of laboratory animals.
Culture of rat MSC
Mesenchymal stem cells were obtained from the bone marrow of adult Lewis 1A rats as previously described [12, 16, 17] . The ends of femurs and tibias were cut, and bone marrow cells (BMC) were aspirated with a 25-gauge needle. To remove all the BMC, the bone canal was flushed with aMEM medium (Sigma-Aldrich, Saint-Quentin Fallavier, France) supplemented with 20% foetal calf serum (FCS; Gibco, Life technologiies ltd, Asint-Aubin, France), 100 U/ml penicillin (Sigma-Aldrich) and 100 lg/ml streptomycin (Sigma-Aldrich). MSC were selected by an overnight incubation of the BMC onto uncoated plastic dishes. Plastic-adherent cells were then plated at a density of 8 9 10 3 cells/cm 2 and split at 80% confluency. Full characterization of the cells was previously described [12, 17] and current analyses by flow cytometry indicate that over 95% of the cells were consistently positive for CD90 and negative for CD45. MSC were used at passage 4.
Preparation of porcine neuroblasts
Foetuses at G28 were collected in Hank's balanced salt solution (GibcoBRL) after hysterectomy. Ventral mesencephalons were dissected under aseptic conditions and conserved in a hibernation medium at 4°C for up to 3 days. Just before transplantation, porcine neuroblasts (pNb) were prepared by mechanical and enzymatic dissociation as previously described [2] and the cell suspension was adjusted to a concentration of~2 9 10 5 cells/ll.
Cell transplantation and surgical procedures
The transplantation was performed on male Lewis 1A rats weighing 250 g. Anaesthesia was performed with an intramuscular injection of 2% Rompun and 50 mg/ml ketamine (1 ml/kg) (PanPharma, Foug eres, France). Anaesthetized rats were placed in a stereotaxic frame (Stoelting, Wood Dale, IL, USA). An amount of 4 9 10 5 pNb, 1 9 10 5 rat MSC or a mix of 3 9 10 5 pNb/1 9 10 5 rMSC was transplanted unilaterally into the striatum (in mm relative to bregma and surface of the dura mater): anterior: +0.7, lateral: À2.8, ventral: À6 and À5.6, incisor bar: À3.3. Injections were performed with a Hamilton syringe placed on an automated microinjector (Phymed, Paris, France) over a time period of 1 min. After a 4-min. delay period, the needle was gently removed, the piece of skull replaced and the skin sutured.
At 28, 35, 42, 63 and 120 days post-transplantation, animals were anaesthetized with an intramuscular injection of 2% Rompun/50 mg/ml ketamine (1 ml/kg) and transcardially perfused with 150 ml 0.9% NaCl, followed by 250 ml cold 4% paraformaldehyde in PBS. The brain was then removed from the skull and cryoprotected in two successive solutions of 15% (24 hrs) and 30% (48 hrs) sucrose in PBS at 4°C. The brains were then frozen in isopentane and stored at À80°C. For the molecular analysis, grafted striata were collected from unperfused animals and directly frozen in liquid nitrogen.
6-hydroxydopamine lesion
Lesion of nigral dopaminergic neurons was carried out by injecting, unilaterally, the 6-hydroxydopamine (6-OHDA) in the medial forebrain bundle. Briefly, rats were anaesthetized with an intramuscular injection of Rompun/ ketamine (1 ml/kg) and placed in a stereotaxic frame (Stoelting). 6-OHDA (3 lg/ll) was dissolved in 0.9% saline/0.1% ascorbic acid, and 4 ll were unilaterally injected (0.33 ll/min) at the following coordinates (in mm relative to bregma and surface of the dura mater): anterior: À4.4; lateral: À1.2; ventral: À7.8; tooth set bar: À2.3. Two weeks after the lesion, the animals were injected with the DA agonist, apomorphine (0.05 mg/kg, s.c.). Only the animals scoring more than 100 contralateral rotations during a 45-min. period were selected for cell transplantation, as this score corresponds tõ 90% of dopaminergic loss on the side ipsilateral to the lesion (Fig. 5A ). Four experimental groups were then constituted: (i) nontransplanted (n = 8), or transplanted (ii) with pig neuroblasts (n = 8), (iii) LEW 1A MSC (n = 8), (iv) MSC plus pig neuroblasts (n = 13). Cell transplantation was performed 1 month after the 6-OHDA lesion.
Cylinder tests
Functional recovery of 6-OHDA-lesioned rats was followed by analysis of forelimb-use asymmetry every 15 days. Rats were placed in a glass cylinder and the number of wall contacts executed independently with the left and right forepaw was counted for each rat (cylinder test) [18] . At least 20 contacts were counted for each animal. Left (contralateral) paw use was expressed as a percentage of the total number of wall contacts, knowing that an unlesioned animal achieves a score of 50%. Total RNA preparation and qPCR analyses To extract total RNA, cells were disrupted in 1 ml TRIzol â (Invitrogen, Carlsbad, CA, USA) and homogenized using a syringe and needle for cells or using an ULTRA-TURRAX T25 (IKA, Staufen, Germany) for tissues according to the manufacturer's specifications.
Potential genomic DNA contamination was removed by treatment with Turbo TM DNase (Ambion Inc., Austin, TX, USA). RNA was quantified using an ND-1000 UV-Vis spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) and RNA integrity was controlled on an agarose gel. cDNA was synthesized from 5 lg total RNA using the Moloney Murine Leukemia Virus reverse-transcriptase kit (Invitrogen) and diluted to a final concentration of 100 ng cDNA/ll.
Analyses of transcripts were performed with a GenAmp 7700 sequence detection system (Applied Biosystems, Life technologies ltd, Saint-Aubin, France) using SYBR Green PCR core reagents (AB). Oligonucleotide sequences are indicated in Table 1 . To minimize the amplification of porcine mRNA, primers were aligned against porcine mRNA sequences and selected as follows: at least, one of the two primers matched on less than nine nucleotides and/or the 3 0 end was free if the homology was greater than 50%. These conditions were not satisfied for Glial Fibrillary Acidic Protein (GFAP) and transforming growth factor-beta (TGF-b). The PCR method and the 2
ÀDDCt quantification method, after normalization to HPRT values, have been described previously. The mRNA expression level is defined as the fold change in mRNA levels in a given sample relative to levels in a calibrator (CB). The calibrator is the 19 expression of each gene. The mRNA expression level is calculated as follows: mRNA expression level = 2
ÀDDCt where DDCt = (Ct Target À Ct HPRT ) sample À (Ct Target À Ct HPRT ) CB . Specific amplifications were checked by amplicon melting curves.
Immunohistochemical analyses
The frozen brains were sliced coronally into 16 lm sections using a cryostat (Leica, Nanterre, France). Parallel series of nine slides, each containing three brain sections, were prepared. The slides were stored at À80°C until further handling. After neutralization of endogenous peroxidase with 0.3% H 2 O 2 in PBS (Sigma-Aldrich) for 10 min., the slides were incubated for 45 min. in 10% normal goat serum (Sigma-Aldrich) diluted in PBS-4% bovine serum albumin (BSA, Sigma-Aldrich) before an incubation with primary antibodies, as presented in Table 2 , overnight at 4°C. After washing, slides were incubated for 1 hr at room temperature with biotinylated antimouse or anti-rabbit Abs (1:500 in PBS-4% BSA). Sections were then washed three times and exposed to avidin-biotinylated-peroxidase complex for 1 hr and revealed with the Vector very intense purple substrate or 3,3-diaminobenzidine (Vector, Laboratories, Burlingame, CA, USA; ABC kit). After several washes in distilled water, slides were dehydrated and mounted using Eukitt (Labonord, Villeneuve d'Ascq, France).
Observations were performed with an Axioskop 2 plus microscope (Zeiss, Marly le Roi, France). Images were acquired using a digital camera (AxioCam HRC, Zeiss) driven by AxioVision Release 4.2 software.
Histological classification of the graft
Brain sections containing the graft were identified by staining one slide of each series with cresyl violet (CV). In the absence of an identifiable graft because of rejection, the needle track or scar was used to localize the injecting point. A minimum of three sections from the graft centre were stained with pNF70 and R73 antibodies to detect porcine neurons and T lymphocytes respectively. The graft status was assessed by two independent readers on blind-coded slides and classified using the following criteria. Healthy grafts: no sign of degeneration (CV 
. Scar: no porcine NF, no T cells. This classification was chosen as it encompassed the five situations observed after the transplantation of pNB into the rat striatum [4, 10, 19] .
Efficiency of the 6-OHDA lesion
The efficiency of 6-OHDA lesion was controlled by analysing the percentage of dopaminergic loss in the substantia nigra compacta. The number of TH-positive cells was counted at three different levels of the SNc using, as a reference point, the exit of the third nerve (200 lm rostral and caudal to this site). Cell counting was performed with the Mercator stereology software (Explora nova, La Rochelle, France). The percentage of loss was expressed as the number of TH + cells on the unlesioned side minus the number of TH + cells on the lesioned side, divided by the number TH + cells at the unlesioned side, and multiplied by 100. The results were analysed by two-way ANOVA.
Results
MSC promote the long-term survival of porcine mesencephalic neuroblasts following their implantation into the striatum of immunocompetent rats
The immunosuppressive and neurotrophic activities of the MSC derived from the bone marrow of Lewis 1A rats prompted us to test their efficiencies to promote the survival of intracerebral xenotransplants. For this purpose, pNb were transplanted into the striata of Lewis 1A rats, with or without Lewis 1A rMSC and the experiments were designed to use the same total number of transplanted cells in all conditions. Survival of the graft was analysed at 28, 35, 42, 63 and 120 days posttransplantation, with a minimum of five rats for each time-point. The presence of porcine neurons in the rat striatum was controlled for using an antibody that specifically recognizes the porcine neurofilament 70 kD subunit (NF70 + ). Infiltration of the graft by T lymphocytes was investigated using R73, an antibody directed against the T-cell receptor. As illustrated in Figure 1 Table 3 , variations in this timing existed between animals, but the rejection process in Lewis 1A rats transplanted with pNb was systematically completed at D63. At this time, only a scar was observed (Scar). The presence of MSC significantly impaired this rejection process. Indeed, all the pNb/MSC grafts looked healthy at D35 and 50% of the rats transplanted with both pNb and rMSC exhibited healthy grafts at D120 (Table 3) .
Characterization of pNb-MSC cografts
In the rats transplanted with pNb, all the transplants exhibited NF70 + cells at D28 ( Fig. 2A and C) . In contrast, no NF70 + cells were detected in any of the cotransplants at D28 (Fig. 2B and D) . NF70 + cells were found in the cotransplants from D35, but only in two of six rats. This percentage increased with time, reaching 100% at D42 (Fig. 2B) . Interestingly, TH + cells were detected in all grafts as soon as they became immunopositive for NF70. In rats transplanted with pNb, TH + cells were found in all transplants at D28. In rats cotransplanted with pNb and MSC, TH + cells were detected at D35, but only in the two animals that were immunopositive for NF70. At D63 and D120, all of the healthy cotransplants exhibited clear NF70 + immunostaining and showed TH + cells ( Fig. 2E-H) . To evaluate the potential migration of the MSC in the brain, the experiment was performed with GFP-MSC [17] . Thirty-five days after the transplantation of pNb and GFP-MSC into the rat striatum, fluorescent MSC were only observed within the graft. No migration of transplanted MSC was detected (data not shown).
Characterization of the host cellular immune response
To characterize the cellular immune response, immunohistochemistry was performed with antibodies directed against activated microglial cells/macrophages (Ox42) and T cells (R73). As previously described, the transplantation of pNb into the striatum of adult immunocompetent rats induced a strong cellular response characterized by a massive infiltration of the graft by T cells and activated microglial cells between D28 and D42. In the rats cografted with MSC, infiltration of the graft by T cells (Fig. 2J ) was never observed before D42 (Table 3) , and at D120 50% of these animals exhibited healthy grafts without any T cells.
To evaluate the impact of MSC on inflammatory markers, the striata of rats transplanted with pNb or pNb-MSC were collected at 28, 35, 42 or 63 days post-transplantation for RNA analyses. Seven or eight animals were culled for each time-point in a given group. Striata from six sham-operated rats were used to determine the basal levels (control). We first analysed the expression of Cb and CD11b as markers of T-cell infiltration and microglial cell activation respectively (Fig. 3) . In rats transplanted with pNb, a sixfold and threefold increase in the levels of Cb and CD11b mRNA was observed at D35, respectively, as compared with the basal levels in control rats. At later stages, such as D42 or D63, Cb and CD11b mRNAs had returned to basal levels. In contrast, we did not observe significant increases in the levels of Cb and CD11b in the rats transplanted with both pNb and MSC at any of the stages analysed. To evaluate a potential impact of MSC on host reactive astrocytes, we analysed the expression of rat GFAP transcripts. The results showed an up-regulation of GFAP mRNA at D28, preceding the peak of CD11b and Cb. The levels of GFAP transcripts further increased, reaching a 5.4-fold increase at D35 and remaining significantly increased at D42. In the rats transplanted with both pNb and MSC, a significant increase in the levels of GFAP mRNA was observed only at D35, and this increase was only 1.7-fold.
We next analysed the expression of chemokines and cytokines that might favour or inhibit the host immune response (Fig. 4) . As reported in Figure 5 , MCP1 and Rantes were significantly up-regulated at D35 in pNb-grafted animals, and the up-regulation of these two chemokines was correlated with the peak expression of Cb and CD11b. We also found, at D28, an up-regulation of the pro-inflammatory cytokines, INFc and IL-6, which preceded the up-regulation at D35 of anti-inflammatory cytokines such as IL-10 and TGF-b. The levels of interferon-c (IFN-c) remained high up to D42 and then strongly decreased, whereas IL-6 returned to its basal level before a second up-regulation at D63. A high level of IL-10 was also observed from 
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D35 to D63, whereas TGF-b returned to its basal level as early as D42. Interestingly, we did not observe any of these regulations in the rats that received both pNb and MSC. The levels of MCP1 and RAN-TES (CCL5), as well as the levels of the four studied cytokines, were not significantly different from their basal levels in control animals at any of the time-points determined. To further characterize the immunomodulatory mechanism triggered by rat MSC in our experimental model, we analysed the expression of iNOS and HO1, two enzymes previously shown to be mediators of MSC function. As shown in Figure 4 , the mRNAs of both of these enzymes were up-regulated in the striata of rats grafted with pNb, with the difference that HO1 expression increased between D28 and D42, whereas the level of iNOS increased between D35 and D63. Interestingly, in the presence of MSC, the up-regulation of HO1 was not observed, whereas the upregulation of iNOS mRNA still occurred.
Effect of cografting on the motor behaviour of 6-OHDA-lesioned rats
To evaluate the functional impact of a pNb-MSC cotransplant, the cells were transplanted in a rat model of Parkinson's disease. Rats lesioned by unilateral injection of 6-OHDA were selected on the basis of their response to the dopaminergic agonist, apomorphine. Postmortem analysis confirmed a minimum of 90% loss of dopaminergic neurons in the substantia nigra pars compacta ipsilateral to the lesion (Fig. 5A and C) . Lesioned rats were transplanted with pNb, or pNb + MSC and motor recovery was assessed every 15 days using the cylinder test. Sham-operated rats were used as controls, but 6-OHDAlesioned rats were also transplanted with 1 9 10 5 rMSC to evaluate a potential impact of this amount of MSC on the motor behaviour. As shown in Figure 5B , no recovery was observed in the rats transplanted with MSC or pNb alone. In contrast, significant signs of motor improvement were observed at D90 and D105 in the group of rats that received both pNb and MSC. As the beneficial effect was no longer significant at D120, the rats were divided according to the presence or absence of transplant. At D120, the rats displayed either a scar (Fig. 5G) or a healthy transplant with NF70 + (Fig. 5E ) and TH + (Fig. 5F ) cells. Intermediate stages were not observed. No activated microglial cells were observed in the control or pNb-MSC-transplanted rats. Inclusion of this parameter in the interpretation of the behavioural tests clearly showed significant recovery in rats displaying a healthy transplant (Fig. 5D ). The rats that exhibited a healthy graft were those that presented the best performance in the cylinder test, whereas the performance of the rats that had rejected their graft was similar to that of the lesioned group that received vehicle (control). Motor recovery in 6-OHDA-lesioned rats was, therefore, correlated with the long-term survival of the pNb-MSC transplants.
Discussion
Our present paper provides the first evidence that cotransplantation of syngeneic MSC with xenogeneic neuroblasts promotes the longterm survival of xenografted neurons and allows motor recovery in a rat model of Parkinson's disease. Behavioural improvement has previously been observed after the transplantation of pNb into the striatum of lesioned rats, but the animals were always treated with high doses of classic immunosuppressors [5, 20, 21] . Here, we show that pNb cotransplanted with rMSC can survive up to 120 days without systemic immunosuppression. This prolonged survival is most probably the result of an immunosuppressive activity, as the loss of xenografted neurons is because of a massive and sudden host immune response at 4-6 weeks [2, 4] . This observation is supported by the description of MSC as potent immunosuppressors, acting at different levels of the immune response [13, 14] . Human MSC alter the maturation of dendritic cells as well as their ability to present antigens to T cells, which is a key point of their activation [22] . They are also able to inhibit T-cell proliferation and to affect the differentiation of B cells into plasmocytes [23] . The MSC isolated from the bone marrow of Lewis 1A rats share similar immunosuppressive properties, as illustrated by their ability to inhibit the proliferation of in vitro-activated T cells and by the limited host immune response in pNb/ MSCcografted rats. Indeed, numerous cellular and molecular events that are usually induced by the implantation of pNb in the rat brain are not observed or are strongly reduced in the presence of MSC. For instance, the accumulation of GFAP mRNA that precedes cell rejection in pNb-grafted rats is strongly reduced in cografted rats, suggesting an inhibition of astroglial activation. The absence of a significant increase in Cb and CD11b levels at the analysed time-points probably reflects a direct or indirect inhibitory effect of MSC on T lymphocyte and microglial cell activation. In vitro analyses raise the possibility of an effect through the secretion of anti-inflammatory molecules such as TGF-b1 or IL10 [16] . However, in vivo analyses did not reveal upregulation of such anti-inflammatory molecules. On the contrary, we observed a general abolition of pro-and anti-inflammatory signals. Indeed, MCP1, RANTES, IFN-c, IL-6, IL-10, TGF-b and HO-1 remained at their basal levels in the striata of rats grafted with both pNb and MSC in contrast to their up-regulation at around D35 in the brains of pNb-grafted rats. Only one molecule was up-regulated in both groups: iNOS. This molecule might be implicated in the immunosuppressive effects of MSC through the production of NO. Indeed, Ren et al. revealed a major role of iNOS in the immunosuppressive properties of mouse MSC [24] and exacerbation of the EAE inflammatory response has been observed in mice deficient for iNOS [25] . The mechanism of action remains to be fully determined, but NO was reported to be a potent inhibitor of T-cell proliferation [26, 27] and leucocyte adhesion on the endothelial cell layer [28] . A local Cylinder test scores at D120 were expressed according to the presence (Graft, n = 4) or absence (Scar, n = 9) of healthy graft in the rat striatum, and compared with the vehicle group (Crtl, n = 8). Mean values AE SEM are presented (one-way ANOVA with Bonferroni post hoc test, *P < 0.05, **P < 0.01). (E-G) At D120, transplanted rats exhibited either a healthy graft with NF70
+ (E, NF staining) and TH overexpression of iNOS by MSC in the cograft might, therefore, favour the long-term survival of the intracerebral xenograft, but molecules other than NO are most probably implicated. Thus, further studies will be required to fully characterize the mechanisms by which MSC promote the long-term survival of xenografted pNb. Neural stem/progenitor cells (NSPC) also display immunosuppressive properties and show prolonged survival in the brains of xenogenic hosts [19, 29] . As they can generate neurons, these cells are considered to be a potential cell source for restorative strategies, but, in fact, very few pNSPC differentiate spontaneously into dopaminergic neurons in vivo [19] . We, thus, considered combining the ability of ventral mesencephalic neuroblasts to generate dopaminergic neurons and the immunosuppressive properties of MSC. The long-term survival of these cotransplants in the brains of xenogenic hosts and their functional effects in a rat model of Parkinson's disease suggest that the intracerebral implantation of 100,000 MSC with 300,000 pNb might be a good basis to develop new restorative strategies with high efficiency and low detrimental secondary effects. Characterization of the mechanisms by which locally implanted MSC contribute to motor recovery in immunocompetent rats should be of great help to optimize such strategies.
